Documente Academic
Documente Profesional
Documente Cultură
Rationale :
recognizes the importance thereof and
acknowledges the responsibility of the
government to accelerate its activities on
prevention and control of neglected tropical
diseases that are implementing the preventive
chemotherapy (PC) strategy specifically
lymphatic filariasis (LF), schistosomiasis (SCH)
and soil-transmitted helminthiasis (STH). As a
response, the DOH is streamlining its strategies
and enhancing resources to successfully
implement mass drug administration (MDA) by
harmonizing the schedule and combining mass
General Objective:
Specific Objectives :
1. To increase MDA coverages to at least 85%
using
the
target
population
as
the
denominator.
2. To improve efficiency of health service delivery
and to maximize limited resources by:
(i) harmonizing the schedule of community &
school based MDA;
(ii)harmonizing the MDA schedules of LF, SCH
and STH; and
(iii)combining drug administration especially for
school aged children
Specific Objectives :
3.To improve quality and timeliness of recording and
reporting for
evidence-based decision making by
ensuring completeness and accuracy of data and by
providing identified deadline periods and mode of
submission.
NUMBER OF
TABLETS
1
1
1
1
2
2
2
2
3
3
3
3
4
4
4
4
TOTAL DOSE
(mg)
450
600
750
900
1050
1200
1350
1500
1650
1800
1950
2100
2250
2400
2550
2700
2850
Alternatively, health
workers may also
use the modified
WHO dose pole for
praziquantel for
school-age children
(SAC) which will be
provided by the
DOH Central Office.
oil-Transmitted Helminthiasis
Albendazole (ALB) or Mebendazole (MBD) for the
prevention, control and treatment of soil-transmitted
helminthiasis.
Dose:
Albendazole 200mg or tablet for children who are
more than 1 but below 2 years old.
Albendazole 400mg or 1 tablet for children who are 2 to
18 years old.
Mebendazole 500 mg for 1 to 18 years old.
Specific Guidelines
Soil-Transmitted
Helminthiasis
TARGET
POPULATION
MONTH
July
5 to 65 years old
January
1 to 4 years old
(Round 1)
January
1 to 4 years old
(Round 2)
July
5 to 18 years old
(Round 1)
July
5 to 18 years old
(Round 2)
January
(of the following
year)
Definition of Terms:
Total Population- is the total number of people
living or residing in a particular endemic area.
Target Population- is the proportion of
individuals/people eligible for treatment from the
Total Population.
AGE GROUP
Lymphatic
Filariasis
Schistosomiasi
s
SoilTransmitted
Helminthiasis
% FROM TOTAL
POPULATION
94.85%
83.66%
10.23%
32.14%
Balance
The
DOH Central Office shall provide an Excel File that will
Master Listing
DOH Regional Office Staff are responsible for reminding their
counterparts on the following:
1. Rural health midwives, with the assistance of other
rural/barangay health workers if available, shall prepare an
official master list of eligible individuals from their latest census
one month before the MDA.
2. The official master list shall contain the following information:
surname and given name, gender, age and address. The official
master list shall also serve as the recording form.
3. Rural/barangay health workers shall request for a copy of school
enrollment from public kinder, elementary and secondary
schools within their barangay to confirm enrolment of schoolage children (5 to 18 years) against the official master list.
4. School-based MDA shall use Form 1-Classroom Level from the
Department of Education Memorandum No. 80, s. 2015,
Annex B.1 as the school master list in public elementary and
secondary schools.
Lymphatic Filariasis
Drug of Choice:
Diethylcarbamazine citrate
and Albendazole
Particularly on DEC
Particularly on DEC
DISEASE
CONTRAINDICATION
Schistosomiasis
Drug of Choice:
Praziquantel
Soil-Transmitted
Helminthiasis
Drug of Choice:
Albendazole or
Mebendazole
No contraindication
RESPONSIBLE
PERSON/S
1. Prepare official master list
Rural Health
Midwife (RHM)
2. Inspect and prepare drug/s taking note of
RHM and other
name, batch number, lot number, expiration
health workers in
date and appearance. This also applies to
the Rural Health
supportive drugs for the management of mild to Unit (RHU) or
moderate adverse events. Report near expiring Barangay Health
or suspicious/odd looking drugs immediately to Station (BHS)
the Municipal/City Health Office. This
information must be shared up to the DOH
Central Office level.
3.Inform community about the schedule of MDA RHM and other
and conduct health education about lymphatic
health workers in
TIMEFRAME
One month
before MDA
before MDA
1-2 weeks
before MDA
ACTIVITY
RESPONSIBLE
PERSON/S
TIMEFRAME
Important reminders:
Assess for any contraindications prior to
administering the drug. Give drugs within 2
hours after a meal.
Observe and manage for any acute mild to
moderate adverse event right after drug
administration. Advise household members to
report any adverse events following MDA to
RHU or BHS, especially serious adverse events.
Adverse events usually happen within 12 hours
after ingesting the drug/s.
Refer individual/s immediately to any
government hospital if adverse event becomes
severe or serious.
Conduct mop up of missed eligible individuals
based on the official master list/recording form.
1 month
RESPONSIBL TIMEFRAME
E PERSON/S
1. Prepare official master list
Rural Health
One month
Midwife
before MDA
2. Inspect and prepare drug/s taking note of RHM and other before MDA
name, batch number, lot number,
health workers
expiration date and appearance. This also
in the RHU or
applies to supportive drugs for the
BHS
management of mild to moderate adverse
Table7.FixedSiteMDAProcedure
(RuralHealthUnit/BarangayHealthStation)
3. Inform community about the schedule of MDA and
conduct health education about lymphatic filariasis,
schistosomiasis and/or soil-transmitted helminthiasis as
appropriate.
4. Conduct fixed site MDA
Important reminders:
Assess for any contraindications prior to
administering the drug. Give drugs within 2 hours
after a meal.
Observe and manage for any acute mild to
moderate adverse event right after drug
administration. Advice individuals to report any
adverse events following MDA to RHU or BHS,
especially serious adverse events. Adverse
events usually happen within 12 hours after
ingesting the drug/s.
Refer individual/s immediately to any government
hospital if adverse event becomes severe or
serious.
Table 8. School Based MDA
ACTIVITY
RESPONSIBLE
Procedure
PERSON/S
TIMEFRAME
One month before
MDA
before MDA
before MDA
2 weeks before
MDA
2 weeks before
MDA
During MDA
1 month
Weekly Report
Final Report
Moderate
Severe
Serious
DEFINITION
An undesirable
experience associated
with the use of
albendazole but not
affecting daily activity.
Those affecting
performance of daily
activities.
Those requiring total rest
and/or medication.
Those requiring
MANAGEMENT
Observe, document and provide supportive
drugs as necessary.
Severe
REPORTING
Together with Final
Accomplishment Report
Immediately
Serious
Immediately
Moderate
Thank
you!